Medical Oncology Live Meeting Series

Gain expert insights from a medical oncologist on the optimal management of thyroid cancer with genomic aberrations in RET or NTRK.

Share

Program Content

Activities

  • Lung and Thyroid Testing
    Genomic Alterations in Lung and Thyroid Cancer: Guidance on Molecular Testing for Precision Therapy
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 10, 2023

    Expires: April 09, 2024

  • Lung and Thyroid Cancer: Mol Alterations
    Genomic Alterations in Lung and Thyroid Cancer: Guidance on Molecular Testing for Precision Therapy
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 17, 2022

Provided by

ProCE Banner

Supporters

Supported by an educational grant from Bayer Healthcare Pharmaceuticals Inc, Blueprint Medicines and Genentech, a member of the Roche Group, and Lilly.

Bayer HealthCare Pharmaceuticals Inc.

Blueprint Medicines and Genentech, a member of the Roche Group

Lilly

Partners

American Society for Clinical Pathology

ProCE Banner